Olga Stasikowska-Kanicka

Prof. Olga Stasikowska-Kanicka


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Pathology and Oncology Research
Verified
Journal Article
Open access
PDF file
OSOlga Stasikowska-Kanicka
Olga Stasikowska-Kanicka
MWMałgorzata Wągrowska-Danilewicz
Małgorzata Wągrowska-Danilewicz
MDMarian Danilewicz
Marian Danilewicz
The immunoexpression of the PD-L1 and the number of immune infiltrating cells have been shown to be a significant prognostic factors in various human cancers. Immunohistochemical method was used to examine the immunoexpression of PD-L1 and number of Foxp3+, CD4+, CD8+ cells in 78 cases of oral squamous cell carcinomas (OSCCs): with better prognosis - OSCCBP (n = 37), and with poorer prognosis - OSCCPP (n = 41), and 18 cases of normal mucosa as a control. The immunoexpression of PD-L1 and the mean number of Foxp3+ cells was significantly increased in OSCCPP group in comparison to OSCCBP and control groups. The mean number of CD4+ cells was significantly increased in OSCCPP group in comparison to OSCCBP and control groups. CD8+ cells were significantly more numerous in OSCCBP group in comparison to OSCCPP and control group. In both OSCCPP and OSCCBP groups there were positive significant correlations between number of Foxp3+ and CD4+ cells. We found positive correlations between the immunoexpression of PD-L1 and numbers of Foxp3+ cells, and negative correlation between the immunoexpression of PD-L1 and numbers of CD8+ cells in both OSCCPP and OSCCBP groups. We found also significant positive correlation between immunoexpression of PD-L1 and the number of CD4+ cells in OSCCPP group. In conclusion, our findings support the hypothesis of involvement of Tregs and PD-L1 in OSCC development and progression.

29 August 2018 in APMIS
Verified
Journal Article
Closed access
PDF file
OSOlga Stasikowska-Kanicka
Olga Stasikowska-Kanicka
MWMałgorzata Wągrowska‐Danilewicz
Małgorzata Wągrowska‐Danilewicz
MDMarian Danilewicz
Marian Danilewicz

1 December 2012 in Advances in Medical Sciences
Verified
Journal Article
Closed access
PDF file
OSOlga Stasikowska-Kanicka
Olga Stasikowska-Kanicka
MDM Danilewicz
M Danilewicz
AGA Głowacka
A Głowacka
MWM Wągrowska-Danilewicz
M Wągrowska-Danilewicz

6 November 2017 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
OSOlga Stasikowska-Kanicka
Olga Stasikowska-Kanicka
MWMałgorzata Wągrowska‐Danilewicz
Małgorzata Wągrowska‐Danilewicz
MDMarian Danilewicz
Marian Danilewicz

6 January 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Adam DaragoAdam Darago
Adam Darago
MKMichał Klimczak
Michał Klimczak
JSJoanna Stragierowicz
Joanna Stragierowicz
OSOlga Stasikowska-Kanicka
Olga Stasikowska-Kanicka
AKAnna Kilanowicz
Anna Kilanowicz
Background: Zinc (Zn) and selenium (Se) play a well-documented role in cancer prevention (e.g., for prostate cancer), and their combined supplementation is often given as a recommended prophylactic agent. The aim of the study was to determine the influence of Zn and/or Se supplementation on the androgen receptor (AR) in the prostate lobes and the serum selected hormone concentrations; a hitherto unresearched topic. Methods: Male rats (n = 84) were administered with Zn and/or Se intragastrically for up to 90 days. The effects of administration on the tested parameters were checked after 30 and 90 days of administration and additionally, 90 days after the end of 90 day administration. Results: Zn alone leads to an increase in serum testosterone concentrations, while the protein expression of AR in both parts of the prostate increases. Combined administration of Zn and Se eliminates the effect of Zn, which may suggest that these two elements act antagonistically. Se supplementation alone results in the same level of AR protein expression in administration and 90 days after administration periods. Conclusion: This paper presents the first report of the influence of Zn and/or Se supplementation on the protein expression of AR in the prostate. Our findings seem to indicate that simultaneous supplementation of both elements may be ineffective.

22 June 2018 in Folia Histochemica et Cytobiologica
Verified
Journal Article
Open access
PDF file
OSOlga Stasikowska-Kanicka
Olga Stasikowska-Kanicka
MWMałgorzata Wągrowska-Danilewicz
Małgorzata Wągrowska-Danilewicz
MDMarian Danilewicz
Marian Danilewicz
Introduction. Neuropilins (NRPs) are multifunctional glycoproteins that play an important role in angiogenesis and cancer progression. The aim of the study was to examine the immunoexpression of neuropilin 1 (NRP1), the number of NRP1+ infiltrating cells and CD163+ macrophages, and density of microvessels (MVD) in oral squamous cell carcinoma (OSCC). Material and methods. The study was performed on 45 OSCC patients with metastases (OSCCM+), 51 patients without metastases (OSCCM-) and 17 control cases. The microvessels were identified by the presence of CD31 and the expression of the studied proteins was assessed by immunohistochemistry. Results. The immunoexpression of NRP1, the mean numbers of NRP1+, CD163+ infiltrating cells, and MVD were significantly increased in OSCCM+ patients in comparison to OSCCM-, and control groups. Moreover, in OSCCM- patients all these parameters were also significantly increased in comparison to controls. In OSCCM+ and OSCCM- groups, there were positive correlations between the immunoexpression of NRP1 and MVD (r = 0.41, p < 0.006; r = 0.51, p < 0.001, respectively), and between the number of NRP1+ infiltrating cells and CD163+ macrophages (r = 0.56, p < 0.001, r = 0.49, p < 0.001, respectively). Conclusions. The present study revealed overexpression of NRP1 in OSCC, especially in OSCC patients with metastasis, suggesting that NRP1 could potentially contribute to metastasis of oral cancer. The correlation between the number of NRP1+ infiltrating cells and CD163+ macrophages suggests that NRP1+ infiltrating macrophages are present in tumor microenvironment and may play a role in the progressions of oral cancer. Introduction. Neuropilins (NRPs) are multifunctional glycoproteins that play an important role in angiogenesis and cancer progression. The aim of the study was to examine the immunoexpression of neuropilin 1 (NRP1), the number of NRP1+ infiltrating cells and CD163+ macrophages, and density of microvessels (MVD) in oral squamous cell carcinoma (OSCC). Material and methods. The study was performed on 45 OSCC patients with metastases (OSCCM+), 51 patients without metastases (OSCCM-) and 17 control cases. The microvessels were identified by the presence of CD31 and the expression of the studied proteins was assessed by immunohistochemistry. Results. The immunoexpression of NRP1, the mean numbers of NRP1+, CD163+ infiltrating cells, and MVD were significantly increased in OSCCM+ patients in comparison to OSCCM-, and control groups. Moreover, in OSCCM- patients all these parameters were also significantly increased in comparison to controls. In OSCCM+ and OSCCM- groups, there were positive correlations between the immunoexpression of NRP1 and MVD (r = 0.41, p < 0.006; r = 0.51, p < 0.001, respectively), and between the number of NRP1+ infiltrating cells and CD163+ macrophages (r = 0.56, p < 0.001, r = 0.49, p < 0.001, respectively). Conclusions. The present study revealed overexpression of NRP1 in OSCC, especially in OSCC patients with metastasis, suggesting that NRP1 could potentially contribute to metastasis of oral cancer. The correlation between the number of NRP1+ infiltrating cells and CD163+ macrophages suggests that NRP1+ infiltrating macrophages are present in tumor microenvironment and may play a role in the progressions of oral cancer.